John Walter JR Hanna, the President and CEO of $CDNA, sold 200 shares of the company on 01-21-2026 for an estimated $4,200. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.0% of their shares of this class of stock. Following this trade, they now own 616,685 shares of this class of $CDNA stock.
$CDNA Insider Trading Activity
$CDNA insiders have traded $CDNA stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $CDNA stock by insiders over the last 6 months:
- JOHN WALTER JR HANNA (President and CEO) has made 0 purchases and 3 sales selling 29,636 shares for an estimated $626,026.
- JEFFREY ADAM NOVACK (Secretary and General Counsel) has made 0 purchases and 4 sales selling 12,669 shares for an estimated $215,907.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CDNA Hedge Fund Activity
We have seen 95 institutional investors add shares of $CDNA stock to their portfolio, and 110 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- INVESCO LTD. removed 2,433,674 shares (-95.7%) from their portfolio in Q3 2025, for an estimated $35,385,619
- DEERFIELD MANAGEMENT COMPANY, L.P. added 2,191,000 shares (+inf%) to their portfolio in Q3 2025, for an estimated $31,857,139
- BRAIDWELL LP added 2,182,781 shares (+inf%) to their portfolio in Q3 2025, for an estimated $31,737,635
- HOOD RIVER CAPITAL MANAGEMENT LLC removed 1,765,981 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $25,677,363
- VANGUARD GROUP INC removed 1,160,864 shares (-23.6%) from their portfolio in Q3 2025, for an estimated $16,878,962
- NEXT CENTURY GROWTH INVESTORS LLC removed 1,125,454 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $16,364,101
- BAMCO INC /NY/ added 719,523 shares (+29.5%) to their portfolio in Q3 2025, for an estimated $10,461,864
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CDNA Revenue
$CDNA had revenues of $100.1M in Q3 2025. This is an increase of 20.72% from the same period in the prior year.
You can track CDNA financials on Quiver Quantitative's CDNA stock page.
$CDNA Analyst Ratings
Wall Street analysts have issued reports on $CDNA in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 11/06/2025
To track analyst ratings and price targets for $CDNA, check out Quiver Quantitative's $CDNA forecast page.
$CDNA Price Targets
Multiple analysts have issued price targets for $CDNA recently. We have seen 2 analysts offer price targets for $CDNA in the last 6 months, with a median target of $21.5.
Here are some recent targets:
- Brandon Couillard from Wells Fargo set a target price of $18.0 on 12/15/2025
- Mark Massaro from BTIG set a target price of $25.0 on 11/06/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
